SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on January 26, 2022. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory disclosure event rather than financial performance data.
Material Changes and Events
- Patent Approval: The U.S. Patent Office has allowed a utility patent covering the Company's PURE EP noise-filtering technology.
- Disclosure Type: The announcement was made pursuant to Item 7.01 (Regulation FD Disclosure) and is furnished via a press release attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this filing. The information provided is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. The filing does not contain specific financial guidance, management commentary on future performance, or a detailed risk assessment beyond standard regulatory disclaimers.
Investor Verification Checklist
- Verify the specific scope and claims of the allowed utility patent for PURE EP technology by reviewing Exhibit 99.1 (Press Release).
- Confirm the commercialization timeline and potential revenue impact of the PURE EP technology, as this filing does not quantify financial benefits.
- Review recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial statements.